Read the rest here:
MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)
Author Archives: Fredricko
Acumen Pharmaceuticals to Participate in Stifel 2023 Virtual CNS Days
Read the original post:
Acumen Pharmaceuticals to Participate in Stifel 2023 Virtual CNS Days
Surrozen Provides Fourth Quarter and Full Year 2022 Financial Results and Update on Clinical Pipeline and Corporate Progress
Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update
Assembly Biosciences Provides Update on its Core Inhibitor Pipeline, Reports Fourth Quarter and Year End 2022 Financial Results and Recent Highlights
Talis Announces Fourth Quarter and Full Year 2022 Financial Results
Go here to see the original:
Talis Announces Fourth Quarter and Full Year 2022 Financial Results
scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update
LifeMD, Inc. Reports Fourth Quarter/ Full Year 2022 Results; Achieves Consolidated Adjusted EBITDA Profitability
Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update
Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences
Read the original post:
Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences
Infant Bacterial Therapeutics publishes Annual Report for 2022
Invivyd Publishes Model for Evaluating Biomarker Correlates of Protection for Monoclonal Antibodies Against Symptomatic COVID-19
Cyclerion Reports Corporate Update and Full Year 2022 Financial Results
See the rest here:
Cyclerion Reports Corporate Update and Full Year 2022 Financial Results
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022
See the original post here:
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022
Context Therapeutics Reports Full Year 2022 Financial Results and Recent Pipeline Updates
Senti Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Reviews Recent Highlights
Cidara Therapeutics and Melinta Therapeutics Announce FDA Approval of REZZAYO™ (rezafungin for injection) for the Treatment of Candidemia and…
Tempest Reports Year End 2022 Financial Results and Provides Business Update
See the original post here:
Tempest Reports Year End 2022 Financial Results and Provides Business Update
CytomX Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 27, 2023
Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALS
See the article here:
Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALS